INSM Stock Analysis: Buy, Sell, or Hold?
INSM - Insmed, Inc.
$111.60
4.60 (4.30%)
▲
5d:
+6.82%
30d:
+7.59%
90d:
-32.31%
BUY
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Smart Money Distribution
None View Scanner →
Strength: 7.8/10
Get Alerted When INSM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: INSM shows positive signals but monitor for confirmation. Market pricing in 41.5% growth. Moderate conviction.
💡 BUY OPPORTUNITY: INSM shows positive signals but monitor for confirmation. Market pricing in 41.5% growth. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: INSM is currently trading at $111.60, which is considered extended relative to its 30-day fair value range of $96.76 to $107.10. From a valuation perspective, the stock is trading at a premium (Forward PE: 807.5) compared to its historical average (285.3). At these levels, the market is pricing in 41.5% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, INSM is in a strong downtrend. The price is approaching resistance at $111.92. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.3% recently.
Market Sentiment: INSM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $197.05 (+76.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, INSM is in a strong downtrend. The price is approaching resistance at $111.92. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.3% recently.
Market Sentiment: INSM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $197.05 (+76.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$96.76 -
$107.10
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.3%)
- BULLISH: Trading 76.6% below Wall St target ($197.05)
- BEARISH: Market expects 41.5% growth - appears too optimistic based on history
Trading Range Analysis
30-Day Trading Range
$96.76 -
$107.10
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$94.00
Resistance Level
$111.92
Current Trend
Strong Downtrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
807.53
Wall Street Target
$197.05
(+76.6%)
Revenue Growth (YoY)
229.6%
Profit Margin
-144.4%
Valuation Premium vs History
+41.5% premium
PE vs Historical
807.5 vs 285.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+41.5%
(market-implied from PE analysis)
1-Year Target
$157.91
(+42%)
2-Year Target
$223.45
(+100%)
3-Year Target
$316.18
(+183%)
3-Yr Target (if PE normalizes)
(PE: 808→285)
PE COMPRESSION
$111.71
(+0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: July 03, 2026 4:36 PM ET
Data refreshes hourly during market hours. Next update: 5:36 PM
Data refreshes hourly during market hours. Next update: 5:36 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INSM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
William Lewis
SELL
10699 shares
2026-04-16
William Lewis
SELL
10699 shares
2026-04-06
Roger Adsett
SELL
88060 shares
2026-04-01
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$436 | 64 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 62 BUY |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$257 | 61 BUY |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 57 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$51 | 62 BUY |
Advanced INSM Option Strategies
Professional options setups generated by AI based on today's INSM price and gamma walls.
